当前位置: 首页 > 期刊 > 《新医学》 > 202010
编号:13802198
重症成人斯蒂尔病一例(5)
http://www.100md.com 2020年10月1日 《新医学》 202010
     [4] 顾史洋, 姜林娣, 陈慧勇, 刘澎. 成人Still病发病机制、诊断标志物及鉴别诊断.内科理论与实践, 2015, 10(1):60-63.

    [5] Kadavath S, Efthimiou P. Adult-onset Still’s disease-pathogenesis, clinical manifestations, and new treatment options. Ann Med, 2015, 47(1):6-14.

    [6] 王臻,姜林娣. 4种成人Still病诊断标准的临床验证. 复旦学报(医学版),2010,37(5):552-554.

    [7] Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizus-hima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T. Preliminary criteria for classification of adult Still’s disease. J Rheumatol, 1992, 19(3):424-430.

    [8] Gerfaud-Valentin M, Maucort-Boulch D, Hot A, Iwaz J, Ninet J, Durieu I, Broussolle C, Sève P. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine(Baltimore), 2014, 93(2):91-99.

    [9] Moore C Jr, Ormseth M, Fuchs H. Causes and significance of markedly elevated serum ferritin levels in an academic medical center. J Clin Rheumatol, 2013, 19(6):324-328.

    [10] Gerfaud-Valentin M, Sève P, Hot A, Broussolle C, Jamilloux Y. Pathophysiology, subtypes, and treatments of adult-onset Still’s disease: an update. Rev Med Interne, 2015, 36(5):319-327.

    [11] 張浩浩,武圣超,张仲博,李沛.成人斯蒂尔病药物治疗的研究进展.中医临床研究,2018,10(25):145-148.

    (收稿日期:2020-02-26)

    (本文编辑:林燕薇), 百拇医药(李文娟?黄祥奇?周宇麒)
上一页1 2 3 4 5